241 related articles for article (PubMed ID: 30383736)
21. Identification of genes involved in the four stages of colorectal cancer: Gene expression profiling.
Shi G; Wang Y; Zhang C; Zhao Z; Sun X; Zhang S; Fan J; Zhou C; Zhang J; Zhang H; Liu J
Mol Cell Probes; 2018 Feb; 37():39-47. PubMed ID: 29179987
[TBL] [Abstract][Full Text] [Related]
22. Identification of Prognostic Biomarker Signatures and Candidate Drugs in Colorectal Cancer: Insights from Systems Biology Analysis.
Rahman MR; Islam T; Gov E; Turanli B; Gulfidan G; Shahjaman M; Banu NA; Mollah MNH; Arga KY; Moni MA
Medicina (Kaunas); 2019 Jan; 55(1):. PubMed ID: 30658502
[TBL] [Abstract][Full Text] [Related]
23. Integrating proteomics and transcriptomics for the identification of potential targets in early colorectal cancer.
Yang W; Shi J; Zhou Y; Liu T; Zhan F; Zhang K; Liu N
Int J Oncol; 2019 Aug; 55(2):439-450. PubMed ID: 31268166
[TBL] [Abstract][Full Text] [Related]
24. Inflammatory genes are novel prognostic biomarkers for colorectal cancer.
Jiang H; Dong L; Gong F; Gu Y; Zhang H; Fan D; Sun Z
Int J Mol Med; 2018 Jul; 42(1):368-380. PubMed ID: 29693170
[TBL] [Abstract][Full Text] [Related]
25. MiR-92a promotes tumorigenesis of colorectal cancer, a transcriptomic and functional based study.
Chen E; Li Q; Wang H; Yang F; Min L; Yang J
Biomed Pharmacother; 2018 Oct; 106():1370-1377. PubMed ID: 30119209
[TBL] [Abstract][Full Text] [Related]
26. Association between PPP2CA expression and colorectal cancer prognosis tumor marker prognostic study.
Yong L; YuFeng Z; Guang B
Int J Surg; 2018 Nov; 59():80-89. PubMed ID: 30296597
[TBL] [Abstract][Full Text] [Related]
27.
Yang Q; Qi M; Chen Y; Tian S; Liao F; Dong W
DNA Cell Biol; 2021 Jul; 40(7):921-935. PubMed ID: 34042518
[TBL] [Abstract][Full Text] [Related]
28. Combined Analysis of ChIP Sequencing and Gene Expression Dataset in Breast Cancer.
Liu P; Jiang W; Zhou S; Gao J; Zhang H
Pathol Oncol Res; 2017 Apr; 23(2):361-368. PubMed ID: 27654269
[TBL] [Abstract][Full Text] [Related]
29. Protein-protein interaction networks and modules analysis for colorectal cancer and serrated adenocarcinoma.
Yu H; Ye L; Wang J; Jin L; Lv Y; Yu M
J Cancer Res Ther; 2015; 11(4):846-51. PubMed ID: 26881529
[TBL] [Abstract][Full Text] [Related]
30. Identification of key genes associated with colorectal cancer based on the transcriptional network.
Chen G; Li H; Niu X; Li G; Han N; Li X; Li G; Liu Y; Sun G; Wang Y; Li Z; Li Q
Pathol Oncol Res; 2015 Jul; 21(3):719-25. PubMed ID: 25613817
[TBL] [Abstract][Full Text] [Related]
31. Profiles of differentially expressed genes and overexpression of NEBL indicates a positive prognosis in patients with colorectal cancer.
Qiu X; Feng JR; Wang F; Chen PF; Chen XX; Zhou R; Chang Y; Liu J; Zhao Q
Mol Med Rep; 2018 Feb; 17(2):3028-3034. PubMed ID: 29257257
[TBL] [Abstract][Full Text] [Related]
32. Identification and verification of HCAR3 and INSL5 as new potential therapeutic targets of colorectal cancer.
Yang X; Wei W; Tan S; Guo L; Qiao S; Yao B; Wang Z
World J Surg Oncol; 2021 Aug; 19(1):248. PubMed ID: 34419055
[TBL] [Abstract][Full Text] [Related]
33. Construction of a Colorectal Cancer Prognostic Risk Model and Screening of Prognostic Risk Genes Using Machine-Learning Algorithms.
Du X; Qi H; Ji W; Li P; Hua R; Hu W; Qi F
Comput Math Methods Med; 2022; 2022():9408839. PubMed ID: 36267311
[TBL] [Abstract][Full Text] [Related]
34. Significance of BMI1 and FSCN1 expression in colorectal cancer.
Alajez NM
Saudi J Gastroenterol; 2016; 22(4):288-93. PubMed ID: 27488323
[TBL] [Abstract][Full Text] [Related]
35. A network-based predictive gene-expression signature for adjuvant chemotherapy benefit in stage II colorectal cancer.
Cao B; Luo L; Feng L; Ma S; Chen T; Ren Y; Zha X; Cheng S; Zhang K; Chen C
BMC Cancer; 2017 Dec; 17(1):844. PubMed ID: 29237416
[TBL] [Abstract][Full Text] [Related]
36. Identification of key tumorigenesis‑related genes and their microRNAs in colon cancer.
Xie B; Zhao R; Bai B; Wu Y; Xu Y; Lu S; Fang Y; Wang Z; Maswikiti EP; Zhou X; Pan H; Han W
Oncol Rep; 2018 Dec; 40(6):3551-3560. PubMed ID: 30272358
[TBL] [Abstract][Full Text] [Related]
37. Identification of candidate biomarkers and pathways associated with SCLC by bioinformatics analysis.
Wen P; Chidanguro T; Shi Z; Gu H; Wang N; Wang T; Li Y; Gao J
Mol Med Rep; 2018 Aug; 18(2):1538-1550. PubMed ID: 29845250
[TBL] [Abstract][Full Text] [Related]
38. Machine learning and network-based models to identify genetic risk factors to the progression and survival of colorectal cancer.
Hossain MJ; Chowdhury UN; Islam MB; Uddin S; Ahmed MB; Quinn JMW; Moni MA
Comput Biol Med; 2021 Aug; 135():104539. PubMed ID: 34153790
[TBL] [Abstract][Full Text] [Related]
39. Paradoxical role of CBX8 in proliferation and metastasis of colorectal cancer.
Tang J; Wang G; Zhang M; Li FY; Sang Y; Wang B; Hu K; Wu Y; Luo R; Liao D; Cao J; Wang X; Wang L; Zhang R; Zhang X; Deng WG; Xie D; Xu RH; Kang T
Oncotarget; 2014 Nov; 5(21):10778-90. PubMed ID: 25360999
[TBL] [Abstract][Full Text] [Related]
40. TNNT2 as a potential biomarker for the progression and prognosis of colorectal cancer.
Jing L; Feng L; Zhou Z; Shi S; Deng R; Wang Z; Zhang Y; Ren Z; Liu Y
Oncol Rep; 2020 Aug; 44(2):628-636. PubMed ID: 32627044
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
